Viewing Study NCT00895557


Ignite Creation Date: 2025-12-24 @ 6:44 PM
Ignite Modification Date: 2025-12-30 @ 5:17 PM
Study NCT ID: NCT00895557
Status: WITHDRAWN
Last Update Posted: 2016-09-08
First Post: 2009-05-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Assessing the Impact of Varenicline on Brain-Behavior Vulnerability
Sponsor: University of Pennsylvania
Organization:

Study Overview

Official Title: Assessing the Impact of Varenicline on Brain-Behavior Vulnerability in Cocaine Dependence
Status: WITHDRAWN
Status Verified Date: 2016-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: This study never started, no funding.
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Our proposal will enable us to study cocaine patients to determine whether varenicline can weaken brain arousal to drug cues in an fMRI imaging setting, which is what we theorize. This supplement supports a pilot imaging study in cocaine dependence. It will evaluate the impact of varenicline on the brain response to ultra-brief drug and comparison cues in an event-related fMRI paradigm. This is a pilot study.

We will additionally examine the impact of varenicline on addiction-relevant behavioral probes of impulsivity, inhibition, attentional and affective bias. The proposed study will provide the first brain-behavioral probes of varenicline's cocaine-relevant actions in humans, and will provide the critical scientific rationale to move the agent into future collaborative clinical trials.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
1P50DA012756 NIH None https://reporter.nih.gov/quic… View
Supplement OTHER_GRANT P50-DA012756 View
DPMC OTHER NIDA View